| Adverse Events Associated With Proton Pump Inhibitors: Fact vs Fiction P Moayyedi Gastroenterology & Hepatology 20 (7), 2024 | | 2024 |
| Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low‐dose rivaroxaban, or the combination: Secondary analysis of the COMPASS randomised … N Forbes, Q Yi, P Moayyedi, J Bosch, DL Bhatt, KAA Fox, JW Eikelboom Alimentary Pharmacology & Therapeutics, 2024 | | 2024 |
| PANCREATIC DUCT GUIDEWIRE PLACEMENT FOR BILIARY CANNULATION FOR THE PREVENTION OF POST-ERCP PANCREATITIS (PEP): AN UPDATED COCHRANE SYSTEMATIC REVIEW AA Bukhari, Y Yuan, G Leontiadis, P Moayyedi, A Barkun, F Tse Gastrointestinal Endoscopy 99 (6), AB724-AB725, 2024 | | 2024 |
| What Is the Role of Tricyclic Antidepressants in the Treatment of IBS? P Moayyedi Curbside Consultation in IBS, 183-185, 2024 | | 2024 |
| Two Years Gone P Moayyedi, D Weinberg Gastroenterology, 2024 | | 2024 |
| Critical appraisal of the SIBO hypothesis and breath testing: A clinical practice update endorsed by the European society of neurogastroenterology and motility (ESNM) and the … P Kashyap, P Moayyedi, EMM Quigley, M Simren, S Vanner Neurogastroenterology & Motility, e14817, 2024 | | 2024 |
| Effect of Brain-gut Behavioral Treatments on Abdominal Pain in Irritable Bowel Syndrome: Systematic Review and Network Meta-analysis. VC Goodoory, M Khasawneh, ER Thakur, HA Everitt, GD Gudleski, ... Gastroenterology, 2024 | 1 | 2024 |
| Mo1915 A MULTICENTER, DOUBLE BLINDED, RANDOMIZED PILOT TRIAL COMPARING FECAL MICROBIOTA TRANSPLANTATION (FMT) TO PLACEBO AT INCUDING CLINICAL AND ENDOSCOPIC REMISSION IN MILD … DH Kao, K Wong, H Jijon, R Franz, N Narula, C Turbide, KI Kroeker, ... Gastroenterology 166 (5), S-1170-S-1171, 2024 | | 2024 |
| Tu1655 DISCLOSURE OF DIET TRIGGERS DOES NOT ALTER DIETARY CHOICES IN PATIENTS WITH IRRITABLE BOWEL SYNDROME (IBS) AND SELFREPORTED GLUTEN SENSITIVITY C Seiler, G Rueda, P Miranda, A Nardelli, R Borojevic, A Hann, ... Gastroenterology 166 (5), S-1367, 2024 | | 2024 |
| Mo1753 IDENTIFYING BLOOD BIOMARKERS THAT PREDICT INFLAMMATORY BOWEL DISEASE: AN OBSERVATIONAL AND MENDELIAN RANDOMIZATION STUDY EC Wong, N Narula, N Perrot, S Danho, N Chang, JK Marshall, ... Gastroenterology 166 (5), S-1097-S-1098, 2024 | | 2024 |
| Sa1850 STOOL FROM HEALTHY FIRST DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS WHO LATER DEVELOP CROHN'S DISEASE ALTERS FECAL METABOLITES AND PROMOTES INFLAMMATION IN GERM-FREE MICE CP Dang, M Xue, A Chen-Liaw, A Luchak, SH Lee, I Mogno, P Moayyedi, ... Gastroenterology 166 (5), S-550, 2024 | | 2024 |
| Su1768 A RANDOMIZED TRIAL OF ANTIMICROBIALS VERSUS PLACEBO IN ADDITION TO FECAL MICROBIOTA TRANSPLANT FOR THE INDUCTION OF REMISSION IN ACTIVE ULCERATIVE COLITIS P Moayyedi, S Halder, N Narula, M Wolfe, G Cappelli, C Onishi, ... Gastroenterology 166 (5), S-804-S-805, 2024 | | 2024 |
| 1159 ASSOCIATION OF ULTRA-PROCESSED FOODS WITH GUT MICROBIOME, GUT PERMEABILITY, AND FECAL CALPROTECTIN IN HEALTHY FIRST DEGREE RELATIVE OF CD PATIENTS K Vagianos, A Neustaeter, AM Waslyk, M Xue, AM Griffiths, P Moayyedi, ... Gastroenterology 166 (5), S-273, 2024 | | 2024 |
| 1091 ASSOCIATION OF AIR POLLUTION WITH RISK OF CROHN'S DISEASE AND BIOMARKERS OF CD RISK IN THE CCC-GEM PROJECT J Shao, M Xue, A Neustaeter, SH Lee, R Panaccione, HQ Huynh, ... Gastroenterology 166 (5), S-261-S-262, 2024 | | 2024 |
| 863 PROTON PUMP INHIBITOR THERAPY DOES NOT INCREASE THE RISK OF VASCULAR LESIONS ON MRI OR COGNITIVE DECLINE: RESULTS OF A DOUBLE BLIND RANDOMIZED, PLACEBO CONTROLLED COMPASS … P Moayyedi, M Sharma, J Eikelboom, J Bosch, Q Yi, S Yusuf Gastroenterology 166 (5), S-197-S-198, 2024 | | 2024 |
| 660 THE SYMPTOM EXPERIENCE OF PERSONS WITH CROHNS DISEASE WITH ACTIVE DISEASE COMPARED TO THOSE WITH INACTIVE DISEASE-THE MAGIC IN IMAGINE STUDY CN Bernstein, Z Nugent, R Panaccione, DA Marshall, G Kaplan, ... Gastroenterology 166 (5), S-157, 2024 | | 2024 |
| 27 DEVELOPMENT AND VALIDATION OF AN INTEGRATED RISK SCORE FOR PREDICTING FUTURE RISK OF CROHN'S DISEASE UP TO 7 YEARS BEFORE DIAGNOSIS IN HEALTHY FIRST-DEGREE RELATIVES: THE … SH Lee, W Turpin, O Espin-Garcia, H Leibovitzh, M Xue, L Grana-Miraglia, ... Gastroenterology 166 (5), S-9-S-10, 2024 | | 2024 |
| Environmental Factors Associated with Risk of Crohn’s Disease Development in the Crohn’s and Colitis Canada-Genetic, Environmental, Microbial Project M Xue, H Leibovitzh, S Jingcheng, A Neustaeter, M Dong, W Xu, ... Clinical Gastroenterology and Hepatology, 2024 | | 2024 |
| The Effects of Pantoprazole on Kidney Outcomes L Pyne, A Smyth, AO Molnar, P Moayyedi, E Muehlhofer, S Yusuf, ... Journal of the American Society of Nephrology, 10.1681, 2024 | 1 | 2024 |
| Measuring the impact of patient engagement in health research: an exploratory study using multiple survey tools DA Marshall, N Suryaprakash, S Bryan, KL Barker, G MacKean, ... Journal of the Canadian Association of Gastroenterology 7 (2), 177-187, 2024 | 3 | 2024 |
Nicholas TalleyThe University of Newcastle在 newcastle.edu.au 的电子邮件经过验证
